GREAT WEST LIFE ASSURANCE CO /CAN/ - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 356 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$90
-80.8%
26,351
-58.7%
0.00%
-100.0%
Q2 2023$469
-32.8%
63,739
-5.4%
0.00%
-50.0%
Q1 2023$698
-24.9%
67,376
-14.2%
0.00%0.0%
Q4 2022$929
-99.9%
78,537
+41.6%
0.00%
-33.3%
Q3 2022$1,163,000
-15.7%
55,447
+24.8%
0.00%
-25.0%
Q2 2022$1,380,000
-20.6%
44,431
+7.8%
0.00%0.0%
Q1 2022$1,737,000
-3.7%
41,229
-0.7%
0.00%0.0%
Q4 2021$1,804,000
+57.6%
41,517
+82.9%
0.00%
+33.3%
Q3 2021$1,145,000
+1.3%
22,704
+26.5%
0.00%0.0%
Q2 2021$1,130,000
-29.9%
17,944
+3.3%
0.00%
-25.0%
Q1 2021$1,612,000
-5.9%
17,366
-9.2%
0.00%
+33.3%
Q4 2020$1,713,000
-22.7%
19,122
-11.0%
0.00%
-40.0%
Q3 2020$2,217,000
-48.8%
21,474
-60.7%
0.01%
-50.0%
Q2 2020$4,326,000
+30.1%
54,677
-5.0%
0.01%
+11.1%
Q1 2020$3,325,000
+14.7%
57,572
+6.3%
0.01%
+50.0%
Q4 2019$2,898,000
-0.6%
54,147
-10.3%
0.01%
-14.3%
Q2 2019$2,915,000
-5.4%
60,369
-1.0%
0.01%
-12.5%
Q1 2019$3,080,000
-4.9%
60,983
+2.9%
0.01%
-11.1%
Q4 2018$3,240,000
-6.0%
59,249
+13.1%
0.01%
+12.5%
Q3 2018$3,448,000
+48.6%
52,394
+13.9%
0.01%
+60.0%
Q2 2018$2,320,000
-4.1%
45,9810.0%0.01%
-16.7%
Q1 2018$2,420,000
+12.6%
45,981
-0.6%
0.01%
+20.0%
Q4 2017$2,149,000
+13.6%
46,280
-2.5%
0.01%0.0%
Q3 2017$1,892,000
+9.7%
47,468
-6.8%
0.01%0.0%
Q2 2017$1,725,000
+24.6%
50,912
+6.8%
0.01%
+25.0%
Q1 2017$1,384,000
-6.5%
47,682
+5.9%
0.00%0.0%
Q4 2016$1,480,000
-49.2%
45,033
-51.3%
0.00%0.0%
Q3 2016$2,912,000
+151.7%
92,410
+124.5%
0.00%
+33.3%
Q2 2016$1,157,000
+769.9%
41,170
+1019.7%
0.00%
Q1 2016$133,000
-9.5%
3,6770.0%0.00%
-100.0%
Q4 2015$147,000
+241.9%
3,677
+144.3%
0.00%
Q3 2015$43,000
-12.2%
1,5050.0%0.00%
Q2 2015$49,000
+14.0%
1,5050.0%0.00%
Q1 2015$43,000
+4.9%
1,5050.0%0.00%
Q4 2014$41,000
+28.1%
1,5050.0%0.00%
Q3 2014$32,000
-5.9%
1,5050.0%0.00%
Q2 2014$34,000
-10.5%
1,5050.0%0.00%
Q1 2014$38,000
+8.6%
1,5050.0%0.00%
Q4 2013$35,0001,5050.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Laurus Investment Counsel Inc. 120,504$10,797,0004.20%
SNYDER CAPITAL MANAGEMENT L P 723,477$64,824,0002.12%
Hillcrest Asset Management LLC 161,428$14,464,0001.97%
RICE HALL JAMES & ASSOCIATES, LLC 587,727$52,660,0001.85%
PALISADE CAPITAL MANAGEMENT, LP 579,009$51,879,0001.33%
Pier Capital, LLC 109,786$9,837,0001.04%
Paradiem, LLC 21,320$2,286,0000.97%
EARNEST PARTNERS LLC 1,390,735$124,610,0000.86%
Ridgewood Investments LLC 10,004$1,034,0000.82%
Tygh Capital Management, Inc. 56,334$5,048,0000.78%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders